What is Regorafenib 40 Mg?
Regorafenib 40 Mg is a prescription medication primarily used in the treatment of advanced colorectal cancer. Manufactured by Natco Pharma Ltd., it contains the active ingredient regorafenib, a multi-kinase inhibitor that targets several proteins responsible for tumour growth and angiogenesis. This medication offers hope for patients in Canada who require additional options after traditional treatments.
Regorafenib 40 Mg is designed to intervene in the complex processes that allow cancer cells to thrive and spread. It is prescribed under careful medical supervision to ensure efficacy and minimize side effects, making it a vital part of cancer care protocols.
Uses of Regorafenib 40 Mg
- Treatment of metastatic colorectal cancer (cancer of colon and rectum) that has progressed after prior therapies
- Management of advanced gastrointestinal stromal tumors (GIST) after failure of other treatments
- Option for patients with hepatocellular carcinoma in select cases
How Regorafenib 40 Mg Works
Regorafenib 40 Mg works by blocking specific enzymes known as kinases, which play a crucial role in cancer cell proliferation, angiogenesis (formation of new blood vessels), and tumour survival. By inhibiting these targets, regorafenib effectively halts tumour growth and spread. This targeted approach helps control the progression of cancer, providing patients with additional time and improved quality of life during treatment.
Benefits of Regorafenib 40 Mg
- Targets multiple pathways involved in tumour growth
- Provides a treatment option for resistant or advanced colorectal cancer
- Helps slow disease progression when standard treatments fail
- Orally administered for convenient patient use
- Backed by clinical studies demonstrating its effectiveness
Dosage and Administration
Regorafenib 40 Mg is typically prescribed as an oral tablet. The standard dosage regimen involves taking one 40 mg tablet daily, usually for 21 days followed by a 7-day rest period to complete a 28-day cycle. Patients must strictly follow their healthcare provider’s instructions to optimize treatment outcomes and reduce the risk of side effects. Doses may be adjusted based on tolerance and clinical response.
Who Should Use Regorafenib 40 Mg?
Patients diagnosed with metastatic colorectal cancer who have exhausted other treatment options may benefit from Regorafenib 40 Mg. It is suitable for adults with an adequate performance status and organ function who are under oncological supervision. The medication is intended for those requiring targeted therapy to manage difficult-to-treat cancer cases effectively.
Who Should Avoid Regorafenib 40 Mg?
Use of Regorafenib 40 Mg should be avoided in individuals with known hypersensitivity to regorafenib or any of its components. It is not recommended for patients with severe liver impairment or uncontrolled hypertension. Pregnant and breastfeeding women should avoid this medication due to potential risks. Patients with significant cardiovascular disease or bleeding disorders require careful evaluation before starting therapy.
Side Effects
- Fatigue and weakness
- Diarrhea
- Hand-foot skin reaction (redness, swelling, blistering)
- Hypertension (high blood pressure)
- Loss of appetite
- Nausea and vomiting
- Abdominal pain
- Elevated liver enzymes
- Skin rash
- Mouth sores or ulcers
- Weight loss
Safety Advice
- Regular monitoring of blood pressure is essential
- Report any unusual bleeding or bruising to your doctor immediately
- Avoid strenuous activities that may cause injury due to increased risk of bleeding
- Maintain adequate hydration to help manage side effects
- Inform your healthcare provider about all other medications and supplements
- Follow dietary recommendations during treatment
- Do not discontinue medication without consulting your oncologist
Drug Interactions
- Medications that affect liver enzymes (CYP3A4 inducers or inhibitors)
- Blood thinners such as warfarin
- Antihypertensive drugs
- Other chemotherapy agents
- Drugs that increase the risk of bleeding
Storage Instructions
Store Regorafenib 40 Mg tablets in a cool, dry place away from direct sunlight. Keep the medication out of reach of children and pets. Ensure the packaging is tightly closed to maintain tablet integrity. Avoid storing in humid environments such as bathrooms.
Where to buy Regorafenib 40 Mg in Canada?
Regorafenib 40 Mg can be purchased through licensed Canadian pharmacies, either in-store or via reputable online platforms. It is important to buy from authorized suppliers to ensure product authenticity and safety. Consult your healthcare provider for prescription details and purchasing options to access this medication legally and securely within Canada.
Frequently Asked Questions (FAQ)
Is Regorafenib 40 Mg available in Canada?
Yes, Regorafenib 40 Mg is available in Canada through prescription from licensed healthcare professionals and can be obtained at authorized pharmacies.
What is the price of Regorafenib 40 Mg in Canada?
The price of Regorafenib 40 Mg varies depending on the pharmacy and insurance coverage. It is advisable to check with local pharmacies or your healthcare provider for accurate pricing information.
What happens if I miss a dose?
If you miss a dose of Regorafenib 40 Mg, take it as soon as you remember unless it is nearly time for your next dose. Do not double the dose to catch up. Consult your doctor if unsure.
Where can I find Regorafenib 40 Mg for sale?
Regorafenib 40 Mg is sold at licensed pharmacies and authorized online medical stores in Canada. Ensure you purchase only from trustworthy sources with valid prescriptions.
Can I take Regorafenib 40 Mg with other cancer medications?
Regorafenib 40 Mg may interact with other cancer treatments. Always inform your oncologist about all medications you are using to avoid adverse interactions.
Are there dietary restrictions while taking Regorafenib 40 Mg?
Your healthcare provider may recommend certain dietary guidelines to help manage side effects. Follow these instructions carefully to support your treatment.
How is Regorafenib 40 Mg best stored at home?
Keep Regorafenib 40 Mg tablets in their original container, stored in a cool, dry place away from moisture and heat, to ensure effectiveness.
Conclusion
Regorafenib 40 Mg is a significant advancement in the treatment of advanced colorectal cancer, offering patients an additional targeted therapy option. Manufactured by Natco Pharma Ltd., it effectively inhibits tumour growth by blocking multiple critical pathways. Proper dosage, regular monitoring, and adherence to medical advice are essential to maximize benefits and manage potential side effects. For patients in Canada seeking to buy Regorafenib 40 Mg, consultation with a healthcare professional and purchase through authorized pharmacies will ensure safe and effective use of this medication.
Leave A Review